| 000 | 01030 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516053742.0 | ||
| 264 | 0 | _c20120109 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1662-2782 | ||
| 024 | 7 |
_a10.1159/000329054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPollock, Jennifer S | |
| 245 | 0 | 0 |
_aEndothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease. _h[electronic resource] |
| 260 |
_bContributions to nephrology _c2011 |
||
| 300 |
_a149-159 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelins _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 700 | 1 | _aPollock, David M | |
| 773 | 0 |
_tContributions to nephrology _gvol. 172 _gp. 149-159 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000329054 _zAvailable from publisher's website |
| 999 |
_c21134676 _d21134676 |
||